The study is currently underway.
AGT103-T, the lead therapeutic in our HIV cure program is currently in Phase 1 clinical trials. This study is taking place at selected clinical sites in the Baltimore/DC Metropolitan area. The trial sites (clinics and hospitals) are solely responsible for recruiting patients that qualify for the study. ClinicalTrials.gov will have the information about our clinical trial here https://clinicaltrials.gov/ct2/show/NCT04561258.
To stay informed on our progress, please also follow us on social media and sign up for our newsletter here https://www.americangene.com/agt-newsletters/ or follow us on social media here: